Plasma CXCL12 levels as a predictor of future stroke

Stroke

Volumn 43, Issue 12, 2012, Pages 3382-3386

  Schutt, Robert C ^a   Burdick, Marie D ^a,b   Strieter, Robert M ^a,b   Mehrad, Borna ^a,b   Keeley, Ellen C ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Biomarker; Chemokine; Stroke

Indexed keywords

STROMAL CELL DERIVED FACTOR 1;

ADULT; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CHEMOKINE CXCL12; CORONARY ANGIOGRAPHY; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84870932444     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.660878     Document Type: Article

References (18)

1. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517-584.
2. World Health Organization. Media Centre Facts Sheets, 2012. Available at: www.who.int/entity/mediacentre/factsheets. Accessed June 30, 2012.
3. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-318.
4. Berger JS, McGinn AP, Howard BV, Kuller L, Manson JE, Otvos J, et al. Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women. Stroke. 2012;43:958-966.
5. Smolders B, Lemmens R, Thijs V. Lipoprotein (a) and stroke: a meta-analysis of observational studies. Stroke. 2007;38:1959-1966.
6. Li M, Ransohoff RM. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol. 2008;84:116-131.
7. Hill WD, Hess DC, Martin-Studdard A, Carothers JJ, Zheng J, Hale D, et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol. 2004;63:84-96.
8. Robin AM, Zhang ZG, Wang L, Zhang RL, Katakowski M, Zhang L, et al. Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab. 2006;26:125-134.
9. Shyu WC, Lin SZ, Yen PS, Su CY, Chen DC, Wang HJ, et al. Stromal cell-derived factor-1 alpha promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats. J Pharmacol Exp Ther. 2008;324:834-849.
10. Yu X, Chen D, Zhang Y, Wu X, Huang Z, Zhou H, et al. Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuro-protection and angiogenesis in a rat model of stroke. J Neurol Sci. 2012;316:141-149.
11. Bogoslovsky T, Spatz M, Chaudhry A, Maric D, Luby M, Frank J, et al. Stromal-derived factor-1α correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients. Stroke. 2011;42:618-625.
12. Paczkowska E, Kucia M, Koziarska D, Halasa M, Safranow K, Masiuk M, et al. Clinical evidence that very small embryonic-like stem cells are mobilized into peripheral blood in patients after stroke. Stroke. 2009;40:1237-1244.
13. Wurster T, Stellos K, Geisler T, Seizer P, Andia ME, Schuster A, et al. Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of isch-aemic stroke? Eur J Neurol. 2012;19:395-401.
14. Prentice R. A case-cohort design for epidemiologic cohort studies and disease trials. Biometrika. 1986;73:1-11.
15. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56: 337-344.
16. Mark SD KH. Specifying and implementing nonparametric and semi-parametric survival estimators in two-stage (nested) cohort studies with missing case data. J Am Stat Assoc. 2006;101:460-471.
17. Katki H. NestedCohort: Survival analysis for cohorts with missing covariate information. R package version 1.2-2. 2009. Available at: http://CRAN.R-project.org/package=NestedCohort. Accessed June 30, 2012.
18. Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res. 2000;86: 131-138.